Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405)
Supplemental materials for: Chang et al
Files in this Data Supplement:
Document 1. Supplemental tables (PDF, 32 KB)